Search
for
Sort by
Research 301–330 of 1000+
- Hereditary Hypotrichosis and Localized Morphea: A New Clinical Entity
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Serum prolactin levels in dermatological diseases: A case–control study
- Pediatric Lichen: Epidemiological and Clinical Characteristics in Children
- Pattern of Cutaneous Manifestations in Systemic Lupus Erythematosus: A Cross-Sectional Hospital-Based Study
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Polarized microscopy in genetic hair disorders: case series
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Reporting on Adverse Clinical Events
- Nitroglycerin in Dermatology
- Skin Disorders in Athletes: Professional and Recreational Sports
- British Hair and Nail Society
- Skin Diseases (Noncancerous)
- Hair Biology and Nutritional Influences
- Clinical Management in Psychodermatology
- Australasian Society for Dermatology Research Meeting, May 2007
- Dermatological adverse events with taxane chemotherapy
- Vitamin D and the skin: Focus on a complex relationship: A review
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Group IID, IIE, IIF and III secreted phospholipase A2s
- INTERFERONS IN DERMATOLOGY
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
- Restoring neuropetide Y levels in the hypothalamus ameliorates premature aging phenotype in mice
- Tacrolimus in Dermatology
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Janus Kinase inhibitors in dermatology: a review
- From a stem-cell–centered to a niche-centered view: the core role of collagen networks in hair loss and hair follicle miniaturization
- Novel drugs of United States Food and Drug Administration approved in 2024